Inspire Medical Systems Inc
INSP
Market Cap$3.86B
Close$
$231.13
75.1% upside
Current Fair Value
75.1% upsideUndervalued by 75.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $3.86 Billion |
|---|---|
| Enterprise Value | $3.84 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $1.8 |
| Beta | 1.29 |
| Outstanding Shares | 29,702,358 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 58.47 |
|---|---|
| PEG | -45.01 |
| Price to Sales | 4.71 |
| Price to Book Ratio | 6.29 |
| Enterprise Value to Revenue | 4.57 |
| Enterprise Value to EBIT | 54.56 |
| Enterprise Value to Net Income | 57 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.05 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Inspire Medical Systems Inc
CEO: Timothy Herbert Inspire is a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea. Inspire's proprietary Inspire therapy is the first and onl...